Libby Amos-Stone

ID: 1b8342de-2619-30fb-68c4

/

Claimed Record

/

Organization: Arnold & Porter Kaye Scholer LLP

Is change on the horizon for the UK product liability regime? [Updated]

BioSlice Blog · February 2, 2026

UK Clinical Trials Reform: Early Growth Indicators and Key MHRA Guidance

BioSlice Blog · January 19, 2026

UK Government to Issue Guidance on Industry Payment Transparency

BioSlice Blog · January 7, 2026

European institutions agree on the reform to the EU Regulatory Framework for Medicinal Products

BioSlice Blog · December 11, 2025

Can a chemically synthesised medicine be authorised as a generic of a biological medicine? And who can challenge this?

BioSlice Blog · November 18, 2025

Practice Areas

Health Care and Life Sciences

Jurisdictions